Valuation Laboratorios Richmond S.A.C.I.F.

Stocks

End-of-day quote Buenos Aires S.E. Other stock markets 06/07/2026			5-day change	1st Jan Change
1,540.00 ^ARS	-2.84%		-1.91%	-22.03%

05-10	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI
05-07	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	9,327	17,927	31,412	56,405	144,949	159,484
Change	-	92.21%	75.23%	79.56%	156.98%	10.03%
Enterprise Value (EV) ¹	10,516	22,242	50,309	149,735	278,596	390,519
Change	-	111.5%	126.19%	197.63%	86.06%	40.17%
P/E	19.2x	30.3x	193x	-5.2x	6.08x	51.6x
PBR	2.76x	3.39x	3.11x	2.5x	2.25x	1.74x
PEG	-	1.4x	-2.7x	0x	-0x	-0.6x
Capitalization / Revenue	1.51x	1.08x	1.7x	1.45x	1.58x	1.26x
EV / Revenue	1.7x	1.34x	2.72x	3.84x	3.04x	3.08x
EV / EBITDA	6.66x	8.95x	15.1x	23.2x	15.3x	11.8x
EV / EBIT	7.07x	9.58x	16.9x	28.3x	17.9x	13.1x
EV / FCF	-27.8x	-9.98x	-5.19x	58x	-49x	-7.4x
FCF Yield	-3.59%	-10%	-19.3%	1.72%	-2.04%	-13.5%
Dividend per Share ²	0.5547	-	-	-	26.89	-
Rate of return	0.48%	-	-	-	1.5%	-
EPS ²	6.02	7.32	2.02	-134.4	295.3	38.24
Distribution rate	9.21%	-	-	-	9.11%	-
Net sales ¹	6,181	16,616	18,470	39,028	91,794	126,726
EBITDA ¹	1,578	2,486	3,326	6,441	18,249	32,999
EBIT ¹	1,487	2,322	2,982	5,299	15,565	29,906
Net income ¹	486.2	591.5	163.4	-10,851	23,845	3,088
Net Debt ¹	1,189	4,315	18,897	93,330	133,647	231,035
Reference price ²	115.50	222.00	389.00	698.50	1,795.00	1,975.00
Nbr of stocks (in thousands)	80,751	80,751	80,751	80,751	80,751	80,751
Announcement Date	10/03/21	09/03/22	09/03/23	11/03/24	07/03/25	06/03/26

¹ARS in Million²ARS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIOS RICHMOND S.A.C.I.F.	-	-	-	-	83.38M
ELI LILLY AND COMPANY	35.08x	12.75x	25.97x	0.57%	1,070B
JOHNSON & JOHNSON	27.67x	6.37x	17.29x	2.06%	624B
ABBVIE INC.	31.08x	7.52x	15.39x	2.69%	450B
ROCHE HOLDING AG	17.65x	4.4x	10.87x	3.02%	328B
NOVARTIS AG	21.61x	5.56x	13.43x	2.84%	284B
NOVO NORDISK A/S	14.17x	5.28x	10.84x	3.53%	217B
AMGEN INC.	23.97x	6.34x	11.16x	2.75%	198B
GILEAD SCIENCES, INC.	-45.95x	5.59x	31.09x	2.5%	161B
PFIZER INC.	11.55x	2.99x	7.34x	7.38%	135B
Average	15.20x	6.31x	15.93x	3.04%	346.76B
Weighted average by Cap.	23.85x	8.00x	18.30x	2.2%